Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.045x

Based on the latest financial reports, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a cash flow conversion efficiency ratio of 0.045x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.84 Billion ≈ $269.92 Million USD) by net assets (CN¥41.12 Billion ≈ $6.02 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Guangzhou Baiyunshan Pharmaceutical Hold to measure how many days the company can operate on defensive assets alone.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd - Cash Flow Conversion Efficiency Trend (2000–2025)

This chart illustrates how Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Telephone and Data Systems Inc NYSE:TDS	-0.007x
Ramelius Resources Ltd AU:RMS	0.233x
Rush Enterprises A Inc NASDAQ:RUSHA	0.038x
HLB Co. Ltd KQ:028300	-0.024x
ENSTAR GROUP LTD DL-01 F:48R	N/A
Octave Intelligence plc NASDAQ:OCTV	0.015x
Sydbank A/S CO:SYDB	-0.099x
GlaxoSmithKline Pharmaceuticals Limited NSE:GLAXO	0.020x

Annual Cash Flow Conversion Efficiency for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)

The table below shows the annual cash flow conversion efficiency of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Guangzhou Baiyunshan Pharmaceutical Hold.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥41.12 Billion ≈ $6.02 Billion	CN¥260.23 Million ≈ $38.08 Million	0.006x	-93.06%
2024-12-31	CN¥37.77 Billion ≈ $5.53 Billion	CN¥3.44 Billion ≈ $503.74 Million	0.091x	-18.54%
2023-12-31	CN¥36.68 Billion ≈ $5.37 Billion	CN¥4.10 Billion ≈ $600.49 Million	0.112x	-46.23%
2022-12-31	CN¥33.64 Billion ≈ $4.92 Billion	CN¥7.00 Billion ≈ $1.02 Billion	0.208x	+14.89%
2021-12-31	CN¥31.33 Billion ≈ $4.58 Billion	CN¥5.67 Billion ≈ $830.21 Million	0.181x	+772.92%
2020-12-31	CN¥28.21 Billion ≈ $4.13 Billion	CN¥585.19 Million ≈ $85.63 Million	0.021x	-89.26%
2019-12-31	CN¥25.99 Billion ≈ $3.80 Billion	CN¥5.02 Billion ≈ $734.93 Million	0.193x	-14.27%
2018-12-31	CN¥23.14 Billion ≈ $3.39 Billion	CN¥5.22 Billion ≈ $763.39 Million	0.225x	+136.80%
2017-12-31	CN¥19.26 Billion ≈ $2.82 Billion	CN¥1.83 Billion ≈ $268.33 Million	0.095x	-31.26%
2016-12-31	CN¥17.65 Billion ≈ $2.58 Billion	CN¥2.44 Billion ≈ $357.73 Million	0.138x	-38.08%
2015-12-31	CN¥8.68 Billion ≈ $1.27 Billion	CN¥1.94 Billion ≈ $284.17 Million	0.224x	+1.05%
2014-12-31	CN¥7.96 Billion ≈ $1.16 Billion	CN¥1.76 Billion ≈ $257.75 Million	0.221x	+16.05%
2013-12-31	CN¥7.02 Billion ≈ $1.03 Billion	CN¥1.34 Billion ≈ $195.96 Million	0.191x	+59.04%
2012-12-31	CN¥4.22 Billion ≈ $618.15 Million	CN¥506.53 Million ≈ $74.12 Million	0.120x	+359.40%
2011-12-31	CN¥3.90 Billion ≈ $569.99 Million	CN¥-180.05 Million ≈ $-26.35 Million	-0.046x	-330.06%
2010-12-31	CN¥3.64 Billion ≈ $532.87 Million	CN¥73.17 Million ≈ $10.71 Million	0.020x	-84.45%
2009-12-31	CN¥3.40 Billion ≈ $497.76 Million	CN¥439.39 Million ≈ $64.30 Million	0.129x	+6725.17%
2008-12-31	CN¥3.22 Billion ≈ $471.91 Million	CN¥6.10 Million ≈ $893.13K	0.002x	-98.34%
2007-12-31	CN¥3.29 Billion ≈ $482.05 Million	CN¥375.74 Million ≈ $54.98 Million	0.114x	+766.65%
2006-12-31	CN¥2.95 Billion ≈ $432.29 Million	CN¥38.88 Million ≈ $5.69 Million	0.013x	-74.75%
2005-12-31	CN¥2.81 Billion ≈ $410.74 Million	CN¥146.32 Million ≈ $21.41 Million	0.052x	-31.47%
2004-12-31	CN¥2.64 Billion ≈ $385.80 Million	CN¥200.54 Million ≈ $29.35 Million	0.076x	+2991.17%
2003-12-31	CN¥2.60 Billion ≈ $379.91 Million	CN¥-6.83 Million ≈ $-999.50K	-0.003x	-103.77%
2002-12-31	CN¥2.42 Billion ≈ $354.54 Million	CN¥169.01 Million ≈ $24.73 Million	0.070x	+13.67%
2001-12-31	CN¥2.28 Billion ≈ $334.18 Million	CN¥140.15 Million ≈ $20.51 Million	0.061x	-67.96%
2000-12-31	CN¥1.50 Billion ≈ $219.25 Million	CN¥286.95 Million ≈ $41.99 Million	0.192x	--

About Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

SHG:600332 China Medical Distribution

Market Cap

$4.27 Billion

CN¥29.21 Billion CNY

Market Cap Rank

#4019 Global

#643 in China

Share Price

CN¥20.78

Change (1 day)

-1.56%

52-Week Range

CN¥20.78 - CN¥27.59

All Time High

CN¥41.57